CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 1 filers reported holding CHEMOCENTRYX INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,826,910 | $264,515,000 | 4.84% |
| Opaleye Management Inc. | 356,000 | $19,509,000 | 3.82% |
| Integral Health Asset Management, LLC | 185,000 | $10,138,000 | 3.10% |
| Cormorant Asset Management, LP | 1,400,000 | $76,720,000 | 2.95% |
| Blue Rock Advisors, LLC | 53,784 | $2,948,000 | 2.54% |
| MANGROVE PARTNERS IM, LLC | 353,219 | $19,356,000 | 2.45% |
| BERYLSON CAPITAL PARTNERS, LLC | 66,400 | $3,639,000 | 1.27% |
| Genesee Capital Advisors, LLC | 27,871 | $1,527,000 | 1.26% |
| GREAT POINT PARTNERS LLC | 253,230 | $13,877,000 | 1.25% |
| Birchview Capital, LP | 60,000 | $3,288,000 | 1.10% |